Anatomy of an Appeal That Won

A won appeal is not a matter of tone. It is a sequence of specific moves, each one closing a gap the denial left open. The trouble is that most overturned appeals are private — settled between a practice, a payer, and a patient, never written down where anyone else can study the argument that worked. California is the exception. Every determination its independent review organizations hand down is published — anonymized at the source, but with the reviewer’s full reasoning intact — in the Department of Managed Health Care’s Independent Medical Review dataset.¹

What follows is one such decision, read the way you would read a winning brief: slowly, move by move. It is a real case — a viscosupplementation injection for knee osteoarthritis, denied by the plan as not medically necessary, then overturned on review in 2022. Nothing here is reconstructed. Each quoted passage is verbatim from the reviewer’s published Findings.

The plan’s position was the strong one on paper. Professional guidelines are genuinely skeptical of viscosupplementation for knee osteoarthritis, and the reviewer says so out loud rather than pretending otherwise: the American Academy of Orthopaedic Surgeons “does not currently recommend viscosupplementation as routine treatment for osteoarthritis of the knees.” A denial that stops at that sentence looks airtight.

It isn’t, because the guideline does not end there. It carves out an exception, and the whole appeal lives inside that exception. The reviewer’s reasoning is a demonstration that this patient is the exception — built from four moves, each quoted below in the reviewer’s own words with the move it performs named in the margin.

Read in sequence, the moves are not four arguments. They are one argument in four parts: the record (moves 1–2) is assembled first precisely so it can be dropped into the guideline’s exception (moves 3–4). The denial lost not because the reviewer out-argued the guideline, but because the appeal brought a record specific enough to fit the guideline’s own escape hatch. The plan cited the rule; the appeal cited the exception and proved the patient belonged in it.

One case is an anecdote. The reason to read it closely is that its structure repeats. Across the DMHC dataset’s 42,749 published determinations spanning 2001 through 2026, plan denials are overturned 52.5% of the time — and on the medical-necessity subset specifically, 55.1%.²The reviewers are practicing specialists in the relevant field, reading the same records the plan read and reaching the opposite conclusion more often than not. That is not a rounding error in the plans’ favor.

Read enough overturned medical-necessity findings and the same skeleton surfaces: a specific clinical record, an itemized history of failed conservative care, the plan’s cited standard restated in full, and then the patient placed inside that standard’s own criterion or exception. The winning appeals rarely argue that the guideline is wrong. They argue that the guideline, correctly applied to this record, points the other way — which is a far easier thing to prove, and a far harder thing for a plan to rebut.

The practical lesson for anyone working a denial is narrow and specific. The reviewer who overturns a denial is not moved by insistence; the finding above contains none. It is moved by a record concrete enough to test, and by an argument that meets the plan’s own criterion on the plan’s own terms. The way you get there is the external-review process — and in California, the mechanics of getting a denial in front of one of these reviewers are set out in the state’s IMR.